Companies
Companies
Revolutionary Partnership Creates Gene-Editing Breakthrough
Title: Intellia and ReCode Partner to Develop Gene-Editing Therapies Against CF Excerpt: 🚀 Exciting collaboration between Intellia and ReCode to combat CF using cutting-edge gene-editing technologies! Stay tuned!
FDA Approves Game-Changing Solid Tumor Cell Therapy!
🚀 Iovance receives FDA approval for groundbreaking solid tumor cell therapy! 💪🔬 Stay tuned for more exciting updates! 🌟
Groundbreaking $800m Cancer Partnership Revolutionizes Treatment
🔍 Sorry, the requested page cannot be found. Please go back to the home page. 🏠 AstellasXyphos Kelonia CancerResearch Partnership
Daiichi Sankyo Skyrockets Oncology Power with $1bn Expansion
🔬💰 Daiichi Sankyo expands its oncology portfolio with a $1bn investment, strengthening their position in the industry. 🏥🚀
Roche Leads $257M Funding for Cancer Detection Breakthrough
🔹 Roche AG leads $257m financing for Freenome Inc., supporting AI-powered blood test for early cancer detection. 🩺💰💉
CDMO Leadership Shuffles: Impact on Biotech
📌 Explore the impact of leadership shuffles at CDMOs in the biotech industry 🌍🔬. Find out why stability matters!
Biogen’s CDMO Revenues Set to Plummet!
📢 Biogen, a global biotech company, anticipates a decline in CDMO revenues as its Denmark commitments conclude. 😔
Revolutionary Partnership Expands Cell Therapy Development
📰 Multiply Labs and Thermo Fisher join forces to revolutionize cell therapy production! 💼🔬 Accelerating development and commercialization for patients. 🏭
Bio-Techne’s CGT Boosts Growth: Q2 Success
📣 Bio-Techne Q2: CGT is a major growth driver! 🧪 Increasing demand, 💼 expanding capacity, and 💰 future growth expected.
Revolutionary Partnership Quantifies Host Cell Proteins
📢 Dyadic International and Cygnus Technologies have partnered to quantify host cell proteins (HCPs) for biopharmaceutical development. 🧫
